Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms
Victor Sandor, Susan Bakke, Robert W. Robey, Min H. Kang, Mikhail V. Blagosklonny, Richard L. Piekarz, William D. Figg, Antonio Tito Fojo, Susan E. Bates, Eben Tucker, Barry Goldspiel, Jonathon Bender, Rebecca Brooks, Kenneth K. Chan, Stanley P. Balcerzak
Research output: Contribution to journal › Article › peer-review
543
Scopus
citations